Boca Raton, United States
VapoCoolShot, Inc. is an innovative healthcare technology startup with a focus on preventing needle pain. The company's flagship product, CoolJect® Targeted Mist™, offers a cost-effective solution for healthcare providers to instantly anesthetize intact skin using proprietary, safe, non-drug technologies. This addresses a significant pain point, as fear of needles affects 2 in 3 children and 1 in 4 adults, often leading to avoidance of necessary medical care.
CoolJect® stands out in the market with its patented syringe holder, providing a streamlined, single-handed experience for healthcare workers. Additionally, its Targeted Mist™ technology reaches anesthetic temperatures quicker than any other topical anesthetic, offering a faster, effective, and lower-cost solution with reduced product usage. These features position CoolJect® as a compelling option for healthcare providers seeking to improve patient experiences and drive revenue growth.
Founded in 2020 and headquartered in the United States, VapoCoolShot, Inc. operates in the Health Care, Manufacturing, and Medical Devices industries. Though details about its last investment and investors are currently unavailable, the company's focus on addressing a prevalent healthcare challenge with an innovative, cost-effective solution presents an intriguing opportunity for potential investors seeking to participate in the evolution of medical procedures and patient care.
Read our IFU before using CoolJect TargetedMist here.
